Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: WHO Identifies Priority Treatment Candidates for Ebola
In today’s Pharmaceutical Executive Daily, Harpreet Singh discusses the evolving regulatory landscape for biopharma, the World Health Organization id…
1 month, 2 weeks ago
Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo
In today’s Pharmaceutical Executive Daily, an FDA advisory committee weighs recommendations for the composition of the 2026–2027 Covid-19 vaccines, C…
1 month, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves Hepcludex
In today’s Pharmaceutical Executive Daily, Eli Lilly announces three acquisitions totaling roughly $3 billion, the FDA approves Hepcludex as the firs…
1 month, 2 weeks ago
Pharmaceutical Executive Daily: What It Takes to Move Machine Learning
In today's Pharmaceutical Executive Daily, Reuters reports that lower-priced oral GLP-1 pills from Eli Lilly and Novo Nordisk are drawing patients aw…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
In today's Pharmaceutical Executive Daily, Eli Lilly announces a deal worth up to $202 million for Engage Biologics and its preclinical non-viral DN…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs
In today’s Pharmaceutical Executive Daily, the Trump administration expands TrumpRx to include more than 600 generic medicines, industry leaders reth…
1 month, 3 weeks ago
Rethinking Pharma's Go-to-Market Formula
In this episode of the Pharm Exec podcast, Mike Petroutsas, president and head of U.S. commercial at Astellas, shares the secrets to building a more…
1 month, 3 weeks ago
Pharmaceutical Executive Daily: FDA Approves Baxdrostat
1 month, 3 weeks ago
Pharmaceutical Executive Daily: FDA Approves AstraZeneca's Fasenra
In today's Pharmaceutical Executive Daily, FDA approves AstraZeneca's Fasenra as a new treatment for hypereosinophilic syndrome in patients 12 years …
1 month, 4 weeks ago